Interestingly, several of the enriched pathways, such as TLR2/4 signaling, Fc receptor signaling, and immune dysregulation during COVID-19, shared overlapping immune-suppressive or inflammatory traits, suggesting that ORMDL2 may be a broad coordinator of tumor inflammation, immune evasion, and apoptosis resistance. Here, TLR2 is linked to neoplasm.